Overall rank by patents
#29,458
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 16 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B60C (VEHICLE TYRES; TYRE INFLATION; TYRE CHANGING; CONNECTING VALVES TO INFLATABLE ELASTIC BODIES IN GENERAL; DEVICES OR ARRANGEMENTS RELATED TO TYRES).
The verdict
Meggitt holds 9 US patents across 16 technology areas, rank #29,458 of 50,000 tracked assignees.
Meggitt Sa has been granted 9 US utility patents between 2015 and 2025, placing Meggitt Sa at rank #29,458 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.0 claims per patent with primary concentration in B60C (VEHICLE TYRES; TYRE INFLATION; TYRE CHANGING; CONNECTING VALVES TO INFLATABLE ELASTIC BODIES IN GENERAL; DEVICES OR ARRANGEMENTS RELATED TO TYRES). As a Foreign Corporation, Meggitt Sa is one of the more focused assignees in the PatentsView dataset. By volume, Meggitt sits between Medivation Prostate Therapeutics Llc (9 patents, rank #29,454) and Merck Chemicals And Life Science AB (9 patents, rank #29,462) - the closest US assignees by grant volume. The composite Innovation Score of 48.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 5 in the 2015–2019 window, a -20% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Meggitt Sa's 21.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 16 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Meggitt Sa against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Medivation Prostate Therapeutics LLC
9 patents
Medtronic SG, LLC
9 patents
Meere Company Inc.
9 patents
Meetkai Inc.
9 patents
Meijer, Inc.
9 patents
Membrain Safety Solutions, LLC
9 patents
MemryX Incorporated
9 patents
Merck Chemicals and Life Science AB
9 patents
Meggitt SA
9 patents
What this shows Meggitt holds 9 patents at rank #29,458, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,458 in granted patent volume.
Other assignees with the most granted patents in Meggitt's primary technology class.
Meggitt's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 22.2% |
| 2016 | 2 | 22.2% |
| 2018 | 1 | 11.1% |
| 2024 | 2 | 22.2% |
| 2025 | 2 | 22.2% |
Top 15 of 16 technology areas
Overall rank by patents
#29,458
Across all tracked assignees
48.0 out of 100
How to use this portfolio
Meggitt's 9 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.